$28.61 0.83 (+2.99%)
11/6/2009 4:00 PM

Dendreon Corp (DNDN)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

Current Price $28.61 Mkt Cap $3.31B
Open $28.19 P/E Ratio 0.00
Prev. Close $27.78 Div. (Yield) N/A (N/A)
Daily Range $27.68 - $28.62 Volume 2,599,827
52-Wk Range $2.55 - $30.42 Avg. Daily Vol. 2,593,000

DNDN News and Commentary

View All DNDN News and Commentary

Caps

How do you think DNDN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

1,109 Outperform
300 Underperform
 

All-Star Members

339 Outperform
94 Underperform
 

Wall Street

13 Outperform
3 Underperform
 

Top DNDN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bhessel (91.05)
Submitted April 14, 2009

BUY Dendreon (DNDN)—potential cure for cancer (again)

Posted by intelledgement on Tue, 14 Apr 09

Yep, we are once again dipping into the Dendreon well. If you were not around in 2007, please read our original pitch for buying… More

5 Comments | Reply | Report this Post

JGus (29.97)
Submitted May 14, 2009

Bet the wrong way on this one. Here's a good lesson for all of you...when it comes to small drug companies, most will fail because the drugs they are developing fail and they run out of money. However, those that actually survive long enough to bring… More

9 Comments | Reply | Report this Post
DNDN VS S&P 500 (SPY)

Fools bullish on DNDN are also bullish on:

Fools bearish on DNDN are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about DNDN.

Recs

2
Member Avatar mullings8454 (< 20) Submitted: 10/30/2009 11:41:33 AM : Outperform Start Price: $25.84 DNDN Score: +8.85

Whole new way of treating cancers, with treatment for breast cancer to follow treatment for prostate cancer. No more chemo or radiation. Amazing technology. Acts like a vaccine. Big companies putting big money into it, i.e. Fidelity Mutual Corp.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar truckeeboy (< 20) Submitted: 10/21/2009 11:48:36 AM : Outperform Start Price: $28.76 DNDN Score: +1.83

Investigational drug ready for FDA approval.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar kaleidoscopic (< 20) Submitted: 10/20/2009 5:41:23 PM : Outperform Start Price: $28.50 DNDN Score: +2.14

6- 09.10.20

Report this Post 0 Comments | Reply | Permalink
View All 328 Pitches »

Leaderboard

Find the members with the highest scoring picks in DNDN.

Score Leader

chd1028

chd1028 (< 20) Score: +957.19

The Score Leader is the member with the highest score across all their picks in DNDN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
chd1028 < 20 3/9/2009 Outperform NS $2.56 +1,017.58% +60.39% +957.19 2 Comments
feew3339 97.43 3/6/2009 Outperform NS $2.62 +991.94% +61.57% +930.37
Bucks1977 67.77 3/6/2009 10/1/2009 Outperform 1Y $2.76 +936.59% +58.13% +878.47
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. i12Bravo 97.76 3/12/2009 6/1/2009 Outperform 1Y $2.82 +914.54% +50.13% +864.41
mojavemystic 39.18 3/12/2009 Outperform 5Y $2.83 +910.99% +49.65% +861.34
Ranoff 86.94 3/11/2009 Outperform NS $2.90 +886.55% +49.34% +837.21 1 Comment
tgga99 98.76 3/3/2009 Outperform 5Y $2.99 +856.86% +52.36% +804.50
westsider317 < 20 3/4/2009 Outperform 5Y $3.02 +847.35% +52.87% +794.48
Pooltableman17 < 20 3/2/2009 Outperform 3M $3.03 +844.22% +50.34% +793.88 1 Comment
cubaislibre 94.63 1/30/2009 Outperform 1Y $3.40 +741.47% +31.06% +710.41
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCanaccord 84.17 10/24/2009 Outperform NS $28.52 +0.32% -2.33% +2.65
TrackLeerinkSwan 84.26 9/22/2009 Outperform NS $29.94 -4.44% +0.08% -4.53
TrackJimCramer < 20 7/7/2009 Outperform 3W $24.02 +19.11% +22.24% -3.13
TrackCitigroup 21.22 6/10/2009 Outperform NS $26.07 +9.74% +13.38% -3.64
TrackDeutscheSec 89.50 6/5/2009 Outperform NS $26.75 +6.95% +13.33% -6.38
TrackMcAdamsWrig 68.91 5/8/2009 Underperform NS $19.29 +34.01% -0.95% -34.96 6/22/2009 @ $25.85
TrackBreanMurray 89.84 4/29/2009 Outperform NS $27.00 +5.96% +25.14% -19.18
TrackWachovia 35.10 4/29/2009 Outperform NS $27.00 +5.96% +25.14% -19.18
TrackNeedham < 20 4/29/2009 Outperform NS $27.00 +5.96% +25.14% -19.18
TrackMerriman < 20 4/22/2009 Outperform NS $20.57 +39.09% +28.42% +10.67
TrackLazardCapit < 20 4/20/2009 Outperform NS $18.66 +53.32% +26.54% +26.78
TrackRodmanRen < 20 4/14/2009 Outperform NS $17.37 +64.69% +27.78% +36.91
TrackZacks 69.52 4/14/2009 Outperform 3M $16.99 +68.39% +28.33% +40.06 1 Comment
TrackMerriman < 20 10/16/2008 Underperform NS $4.95 +315.56% -6.27% -321.83 4/22/2009 @ $20.57
TrackJMP < 20 7/12/2007 Underperform NS $7.88 +263.07% -25.99% -289.06
TrackBreanMurray 89.84 5/11/2007 Underperform NS $5.13 +250.88% -42.89% -293.77 4/14/2009 @ $18.00
TrackBofASec 93.50 5/10/2007 Underperform NS $5.75 +397.57% -24.86% -422.43
TrackUBS 86.41 5/8/2007 Underperform NS $17.14 +66.92% -24.77% -91.69
TrackJimCramer < 20 5/7/2007 Underperform 3W $17.92 +34.04% -41.66% -75.70 7/8/2009 @ $24.02
TrackNextGen 62.38 5/3/2007 Outperform NS $18.13 +57.80% -24.50% +82.30
TrackJimCramer < 20 4/5/2007 Outperform 3W $18.05 -0.72% +4.65% -5.37 5/8/2007 @ $17.92
TrackJMP < 20 3/30/2007 Outperform NS $17.92 -62.95% +7.21% -70.15 5/24/2007 @ $6.64
TrackJimCramer < 20 3/28/2007 Underperform 3W $5.22 +245.79% +1.71% -244.08 4/6/2007 @ $18.05

Featured Broker Partners